Stefan Lethagen (Former)
41 – 50 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
- Contribution to journal › Article
-
Mark
Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
- Contribution to journal › Article
-
Mark
Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.
- Contribution to journal › Letter
-
Mark
Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
- Contribution to journal › Article
-
Mark
Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.
- Contribution to journal › Article
-
Mark
Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?
- Contribution to journal › Article
- 2002
-
Mark
The prognostic value of global haemostatic tests in the intensive care unit setting.
- Contribution to journal › Article
-
Mark
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
- Contribution to journal › Article
- 2001
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
- Contribution to journal › Article
-
Mark
No increased risk of venous thrombosis in women taking tranexamic acid
- Contribution to journal › Letter
